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Abstract This article describes the synthesis of silver
nanoparticles using the aqueous extract of Alternanthera
sessilis as a reducing agent by sonication, espousing green
chemistry principles. Biologically synthesized nanoparti-
cle-based drug delivery systems have significant potential
in the field of biopharmaceutics due to its smaller size
entailing high surface area and synergistic effects of
embedded biomolecules. In the present work the cytotoxic
effect of biosynthesized silver nanoparticles studied by
MTT assay against breast cancer cells (MCF-7 cell line)
showed significant cytotoxic activity with IC50 value
3.04 lg/mL compared to that of standard cisplatin. The
superior activity of the silver nanoparticles may be due to
the spherical shape and smaller particle size 10–30 nm as
confirmed from transmission electron microscope (TEM)
analysis. The data obtained in the study reveal the potent
therapeutic value of biogenic silver nanoparticles and the
scope for further development of anticancer drugs.
Keywords Nanosilver  Cytotoxicity  Alternanthera
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Introduction
Infection paves a pathway to non-communicable diseases
such as cardiovascular disease and cancer. Cancer is a
multifaceted genetic disease caused primarily by
environmental factors and its treatment is usually a com-
bination of numerous varied modalities. Different types of
cancers can behave very differently. Among these lung
cancer and breast cancer are very disparate diseases. Breast
cancer is a malignant tumor that starts in the breast cells
and occurs particularly in women (Alison 2001). The
Times of India (12 Oct. 2012) estimates 1,00,000–1,25,000
new breast cancer cases in India every year. This statistical
number is estimated to double by 2025. The mortality rate
of patients and the must for cancer therapy coerces the need
for technological breakthroughs in terms of easy avail-
ability, cost effectiveness and safety in terms of side
effects. Paclitaxel, an FDA approved breast cancer drug is
used widely in breast cancer treatments. It is alleged to
have a string of side effects. These stipulate the need for
herbal medicines in cancer therapy.
Nanomedicine is an upcoming field that could poten-
tially make a major impact on human health (Teli et al.
2010). Nanoparticles possess unique chemical, physical
and biological properties, and hence it finds use in various
fields like business, therapeutics, electronics, cosmetics,
catalysis and drug delivery (Sriram et al. 2012). It offers a
new view for tumor detection, prevention and treatment.
Nanoparticles eradicate cancer cells by flow and penetra-
tion to different regions of tumors through blood vessels
and then to interstitial space to arrive at the target cells.
The environmental and physiological characteristics vary
from one tumor tissues to another. Hence nanoparticles
should be designed in such manner, taking into account the
target site and route of administration to generate optimal
therapeutic effects (Wang et al. 2014).
Among nanoparticles, silver nanoparticles have an eye-
catching role owing to their innumerable physical and
chemical properties. Silver nanoparticles are more potent
than the silver ions as revealed in avant-garde research.
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Silver nanoparticles are potential anticancer agents
(Raghunandan et al. 2011). Cytotoxicity studies of silver
nanoparticles using plant extracts: Melia dubia—human
breast cancer cell line (Kathiravan et al. 2014), Malus
domestica (apple) extract—MCF7 (Lokina et al. 2014),
Inonotus obliquus (Chaga mushroom) extract—A549
human lung cancer (CCL185) and MCF7 human breast
cancer (HTB22) cell lines (Nagajyothi et al. 2014), Ery-
thrina indica—breast and lung cancer cell lines (Rathi Sre
et al. 2015), Piper longum fruit—breast cancer cell lines
(Reddy et al. 2014), Annona squamosa and Brassica
Oleracea. var. botrytis—MCF-7 (Vivek et al. 2012; Ran-
jitham et al. 2013) are reported.
Silver nanoparticles synthesized using Acalypha indica
Linn shows only 40 % cell inhibition against human breast
cancer cells (MDA-MB-231) (Krishnaraj et al. 2014). The
MCF-7 cells lose their 50 % viability with AgNPs (5 lg/
mL) produced by Dendrophthoe falcata (Sathishkumar
et al. 2014). Datura inoxia AgNPs inhibits 50 % prolifer-
ation of human breast cancer cell line MCF7 at 20 lg/mL
after 24 h incubation by suppressing its growth, arresting
the cell cycle phases, reducing DNA synthesis to induce
apoptosis (Gajendran et al. 2014). Nuclear condensation,
cell shrinkage and fragmentation are noticed for MCF-7
cells treated with Sesbania grandiflora mediated AgNPs
(20 lg/mL) after 48 h in Hoechst staining.
Morinda citrifolia root extract-mediated AgNPs
(100 lg) produced 100 % death of HeLa cell lines (Suman
et al. 2013). Longer exposures to Eucalyptus chapmaniana
AgNPs (0.02 mmol/mL) resulted in 85 % cell death after
24 h incubation (Sulaiman et al. 2013a, b). The viability of
HL-60 cells decreased to 44 % after 6 h treatment with
Rosmarinus officinalis AgNPs at 2 mM and cell death
increased to 80 % after 24 h incubation (Sulaiman et al.
2013a, b). Cytotoxic activity was extremely sensitive to the
size of the nanoparticles produced using Iresine herbstii
leaf and the viability measurements decreased with
increasing dosage (25–300 lg/mL) against the HeLa cell
lines (Dipankar and Murugan 2012). Piper longum-medi-
ated silver nanoparticles exhibit a significant cytotoxic
effect (94.02 %) at 500 lg/mL on HEp-2 cell lines (Jacob
et al. 2012). The therapeutic effect of silver nanoparticles
may elicit through manipulation of their size, shape, ele-
mental composition, charge and surface modification or
functionalisation, leading target particles to specific organs
(Thorley and Tetley 2013).
Owing to the significance of silver nanoparticles in
cancer treatment and the necessity for newer breast cancer
drugs, the present work spotlights the cytotoxic potential of
the synthesized biogenic silver nanoparticles. Amid the
cropping methods of nanosynthesis, biogenic synthesis
finds healthier application in pharmacology due to the non-
toxic nature of the source of capping material used.
Alternanthera sessilis is a weed growing on a variety of soil
types. Its young shoots and leaves are ingested as vegetables.
Phytochemical screening reveals the presence of reducing
sugars, steroids, terpenoids, saponins, tannins and flavonoids in
A. sessilis (Sahithi et al. 2011). The herb possesses antioxidant
(Borah et al. 2011), anti-inflammatory (Sahithi et al. 2011),
antipyretic (Nayak et al. 2010), haematinic (Arollado and Osi
2010), hepatoprotective (Lin et al. 1994), antiulcer (Pur-
kayastha and Nath 2006), antimicrobial (Jalalpure et al. 2008),
diuretic (Roy and Saraf 2008) and cytotoxic (Balasuriya and
Dharmaratne 2007) activities. The herb is also reported as
febrifuge, galactagogue, abortifacient, and used in the treat-
ment of indigestion (Anandkumar and Sachidanand 2001). The
plant is reported to contain lupeol, a and b-spinasterol, b-si-
tosterol, stigmasterol, campesterol, handianol,
24-methylenecycloartanol, cycloeucalenol and 5a-stigmasta-
7-enol (Jou et al. 1979; Sinha et al. 1984).
High levels of ellagic acid and rutin are reported in the
HPLC analysis of the ethanolic extract ofA. sessilis (Mondal
et al. 2015). Ellagic acid possesses a selective antiprolifer-
ative activity and induces apoptosis in Caco-2 colon, MCF-
7, Hs 578T and DU145 cancer cells (Losso et al. 2004).
Ellagic acid down-regulates the 17b-estradiol-induced
hTERT a ? b ? mRNA expression and exerts chemopre-
ventive effects in breast cancer (Strati et al. 2009).
With the aforesaid background necessitating research in
newer breast cancer drugs, the present work is aimed at
assessing the anticancer potential of plant-mediated silver




Fresh aerial parts of A. sessilis were used to produce silver
nanoparticles from silver nitrate. The aqueous extract of A.
sessilis was treated with of silver nitrate (3 mM) solution
(1:10) and sonicated using ultrasonic bath {Ultrasonics
[1.5 L (H)]}. The optimized conditions for the formation of
silver nanoparticles are reported in our earlier paper
(Firdhouse and Lalitha 2013). The nanosilver formed was
purified by repeated centrifugation and characterized.
Characterization of silver nanoparticles
The nanoparticle formation was ascertained by recording
UV–visible spectra (double beam spectrophotometer 2202-
Systronics). The morphology and the particle size of the A.
sessilis extract-mediated silver nanoparticles were charac-
terized by transmission electron microscopy (FEI’s Tec-
naiTM G2 transmission electron microscope (TEM)).
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In vitro cytotoxicity study of silver nanoparticles
Cell culture
Human breast cancer cell line (MCF-7) was purchased from
National Centre for Cell Science (NCCS), Pune. The cancer
cells were grown in Eagle’s minimum essential medium
(EMEM) containing 10 % fetal bovine serum (FBS) and
maintained at 37 C, 5 % CO2, 95 % air and 100 % relative
humidity.
Cell treatment procedure
The monolayer cells were detached with trypsin–ethylene
diamine tetra acetic acid (EDTA) to make single cell suspen-
sions. The viable cells were counted using a hemocytometer.
The cell solutionwas dilutedwithmediumcontaining5 %FBS
to give final density of 1 9 105 cells/mL. The cell suspensions
(100 lL/well) were seeded onto 96-well plates, maintaining
the plating density as 10,000 cells/well and incubated at 37 C,
5 % CO2, 95 % air and 100 % relative humidity for cell
attachment to the bottomof thewells. After 24 h, the cells were
treated with serial concentrations of the nanosilver samples.
The nanosilver samples were passed through a 0.45-lm
filter syringe. An aliquot (100 lL) of the sample solution
was diluted to 1 mL with serum free medium. Twofold
serial dilutions were made to provide a total of five sample
concentrations. Varying concentrations (1.56, 3.12, 6.25,
12.5, 25 lL/mL) of silver nanoparticles were inoculated
into grown cell containing 100 lL medium. Then the plates
were incubated for 48 h at 37 C, 5 % CO2, 95 % air and
100 % relative humidity. Varying concentrations (0.1, 1,
10, 50, 100 lM) of cisplatin were used as standard. The
study was run in triplicate to ensure accuracy of the results.
MTT assay
The yellow solution of 3-[4,5-dimethylthiazol-2-yl] 2,5-
diphenyltetrazolium bromide (MTT) (15 lL) was added to
phosphate buffered saline (5 mg/mL) in each well. The
plates were incubated at 37 C for 4 h for the reduction of
MTT. The resulting purple formazan crystals were solubi-
lized in 100 lL of DMSO and the absorbance was measured
at 570 nm using a micro plate reader (EMR500-Labomed).
The cell inhibition (%) was calculated using the formula:
Cell inhibition ð%Þ ¼ 100 Abs sampleð Þ=Abs controlð Þ½ 
 100:
A non-linear regression graph was plotted between cell
inhibition (%) and log10 concentration and the 50 % min-
imum inhibitory concentration (IC50) was determined using
Graph Pad Prism software.
Results and discussion
The fresh aqueous extract of A. sessilis and silver nitrate
solution was mixed in 1:10 ratio and sonicated for 45 min.
The yellow color solution changed to reddish-brown indi-
cating the formation of silver nanoparticles. The comple-
tion of reduction of silver ions to nanosilver is evidenced
from the broad surface plasmon resonance (SPR) band
(420–450 nm) in the UV–visible spectra (Fig. 1). TEM
analysis revealed the spherical morphology of the
nanosilver with particle size in the range 10–30 nm
(Fig. 2).
The in vitro cytotoxic effect of silver nanoparticles
against breast cancer cell lines (MCF-7) and cell inhibition
(%) was carried out by MTT assay and compared with the
standard cisplatin. Cisplatin, the commercially available
anticancer drug, was used as standard and its cytotoxicity is
shown in Fig. 3a–c. Comparison of the cytotoxicity of
synthesized AgNPs (1.56, 3.12, 6.25, 12.5, 25 lL/mL) and
cisplatin (0.1, 1, 10, 50, 100 lM) disclosed similar mor-
tality rate. The cytomorphological changes of AgNPs on
MCF-7 cell lines at different concentrations (1.56, 6.25,
25 lL) involve intracellular suicide program possessing
morphological changes like cell shrinkage, oxidative stress,
coiling and biochemical response leading to apoptosis as
shown in Fig. 4d–f. It is quite obvious from the results that
the apoptosis rate of MCF-7 cell lines increases with
increase in concentration of silver nanoparticles (Fig. 5a).
A dose-dependent increase in cell inhibition is seen after
48 h exposure The IC50 of cell inhibition of silver
nanoparticles was observed at 3.043 lL/mL. The complete
cell inhibition (99 %) of breast cancer cell lines was
obtained at a maximum concentration of 25 lg/mL. These
results evidence the dose- and time-dependent increase in
Fig. 1 UV–visible spectrum of Alternanthera sessilis extract-medi-
ated silver nanoparticles
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cytotoxicity. The IC50 value predicts that the plant-medi-
ated nanosilver proves to be a promising drug for
chemotherapeutic treatment. Complete apoptosis was
observed with 25 lg/mL of AgNPs, whereas it is 30 lg/mL
(or 100 lM) for cisplatin.
Alternanthera sessilis is enriched with flavonoids, glyco-
sides, sugars, amino acids and steroids. Flavonoids are
polyphenols which exhibit a wide variety of biological activ-
ities such as antioxidant, antibacterial, antiviral, anti-inflam-
matory and anticancer (Jogendra et al. 2012). There are reports
on appreciable (86 %) cytotoxic activity of the chloroform
fractionate of methanol extract of A. sessilis at maximum
concentration (100 lg/mL) (Chan et al. 2008). AlternanthinB,
a flavonoid isolated from Alternanthera philoxeroides species
is known to possess antitumor activity (Zhou et al. 1988).
Ragasa et al. (2002) reported that the chloroform extract of the
air-dried leaves of A. sessilis afforded a mixture of diastere-
omers of new ionone derivatives which are anti-proliferative
agents. The HPLC of ethanolic extract of A. sessilis evidences
ellagic acid to be a prominent chemical constituent. Ellagic
acid possesses antiproliferative activity.
Mode of action of drugs on cancer cells
A thorough review of literature embarks the different
mechanisms of drug action on cancer cells. Interference of
the electron transport mechanism of the cell by silver ions
inhibits the respiratory mechanism as the silver cation
readily oxidizes ATP resulting in the formation of silver
(0). The replication and protein encoding of the bacteria get
disrupted by the binding capability of silver to the DNA
and RNA. The bacterial cell disruption aided by silver is
similar to that of the action of platinum complex anticancer
drug, cisplatin (Youngs et al. 2012).
Cisplatin, an anticancer drug has been commercially
developed for selective killing of cancerous cells without
any effect on non-cancerous or normal cells. Drugs used in
cancer therapy enhance permeability and retention (EPR)
effect, passively targeting the leaky vasculature of the tumor
cells, since the cancer cells do not have a strong vasculature
system compared to that of normal cells. Hence, the pene-
tration of the drugs is easier and finally kills the cancer cells,
but sometimes it enters into the normal cells and cause toxic
effects (Jaracz et al. 2005; Blanco et al. 2009; Luo and
Prestwich 2002; Leamon and Reddy 2004; Salazar and
Ratnam 2007; Yoo and Park 2004).
To overcome these facets, the drugs can be loaded with
nanoparticles and targeted moieties on the surface which
Fig. 2 TEM micrograph of the biogenically synthesized silver
nanoparticles
Fig. 3 Cytomorphological changes and growth inhibition of cisplatin
on MCF-7 cell line at a 0.1 lM, b 10 lM and c 100 lM
concentrations
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will act against the particular receptor without affecting the
normal cells. Many receptors have been discovered for
cancer drug targeting, the commonly used one is folic acid
(Kim 2006). The aqueous extract of Taxus baccata syn-
thesized silver nanoparticles revealed potent anticancer
effects on MCF-7 cells with an IC50 value of 0.25 lg/mL
by MTT assay (Kajani et al. 2014). AntiABCG2 mono-
clonal antibody combined with AgNPs and Vincristine
provide an efficient, targeted therapeutic method for
inhibiting myeloma growth in mice (Dou et al. 2013).
MDA-MB-231 breast cancer cells exposed to Ganoderma
neojaponicum Imazeki-AgNPs after 24 h showed increased
production, reactive oxygen species and hydroxyl radical.
The apoptotic effects of AgNPs were further confirmed by
the activation of caspase 3 and DNA nuclear fragmentation
(Gurunathan et al. 2013a, b). The cytotoxicity of T.
divaricata leaf extract synthesized AgNPs against human
breast cancer cell indicates the presence of significant
amounts of reducing entities (Devaraj et al. 2014).
Enhanced cytotoxic activity was observed for MCF-7
than A549 cells due to the increased cytotoxicity,
decreased viability and proliferation which result in apop-
tosis through induced programmed cell death by irradiated
AgNPs (MfouoTynga et al. 2014). The differential
response of breast cancer cells to AgNPs induced hyper-
thermia, which implies AgNPs to be effective photothermal
agents (Thompson et al. 2014). Apoptosis could be acti-
vated through Bax/BCl2 and caspase cascade mediated
mitochondrial dysfunction, which potentially inhibits the
proliferation of MCF-7 cells (Jeyaraj et al. 2015).
Proposed mode of action of nanosilver on MCF-7
cells
Figure 6 is the proposed mode of action of biogenically
synthesized nanosilver embedded with ellagic acid on
breast cancer cell lines. The nature of plant extract directly
affects the physical, chemical and cytotoxic properties of
the nanoparticles due to the interaction of nanoparticles
with cells and intracellular macromolecules like proteins
and DNA. Cellular uptake of nanoparticles leads to gen-
eration of reactive oxygen species which provoke oxidative
Fig. 4 Cytomorphological changes and growth inhibition of silver
nanoparticles on MCF-7 cell line at d 1.56 lL, e 6.25 lL and f 25 lL
concentrations






































Fig. 5 Cytotoxicity of Alternanthera sessilis-embedded silver nanopar-
ticles (a) and cisplatin (b) on human breast cancer MCF-7 cell lines
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stress. Cell damage by silver nanoparticles may be due to
loss of cell membrane integrity, apoptosis and oxidative
stress. A.sessilis is rich in beta ionones and flavonoid
Alternanthin B the structures of which are given below.
Molecules with ionone rings and Alternanthin B are known
anti-tumor agents, though the mechanism of action is not
well-defined in literature.
b-Ionone is an end-ring analog of b-carotenoid which
possesses potent antiproliferative activity. Mo and Elson
(2004) demonstrated that b-ionone and a variety of iso-
prenoids can inhibit the growth of malignant cells in dif-
ferent experimental models. The cell cycle was arrested in
the human gastric adenocarcinoma cancer cell lines treated
with b-ionone by inhibition of cell growth and DNA
synthesis in a dose-dependent manner and this may be
regulated by mitogen-activated protein kinase pathways
(Liu et al. 2004; Dong et al. 2013). The impaired activity of
cyclin-dependent kinase (CDK) 2 and decreased expression
of positive regulators of G1 to S phase progression aided
by mevalonate depletion results in a G1 phase cell cycle
arrest. The inhibition of HMG-CoA reductase activity also
mediates the depletion of mevalonate which contributes to
the cell cycle inhibitory and anti-proliferative effects of b-
ionone on human breast cancer cells (MCF-7) (Duncan
et al. 2004).
The flavonoid rings and ionone rings might have inter-
fered with the gene expression, immune modulation and
would have boosted the antioxidant effect resulting in
Fig. 6 Proposed mode of action of ellagic acid-embedded silver nanoparticles on MCF-7 cell line
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apoptosis and death of cancer cells. Further studies are
needed to optimize the mechanism of AgNPs on cancer
cells.
The mechanism of ellagic acid on MCF-7 cell lines is
reported. The inhibition of proliferation of MCF-7 breast
cancer cells is through the modulation of the TGF-b/Smad3
pathway associated with decreased phosphorylation of RB
proteins (Zhang et al. 2014). Blueberry extracts, rich in
ellagic acid, modulate the PI3K/AKT/NF kappa B path-
way, and inhibits the growth and metastasis of MDA-MB-
231 breast cancer cells (Adams et al. 2010). Treatment with
ellagic acid arrests G0/G1 cell cycle and induces apoptosis
in bladder cancer T24 cells (Li et al. 2005). It also induces
apoptosis through G1/S cell cycle arrest in SW480 colon
cancer cells (Narayanan and Re 2001). Han et al. (2006)
reported ellagic acid to significantly reduce HOS cell
proliferation and induce apoptosis as evidenced by chro-
mosomal DNA degradation and through the upregulation
of Bax and activation of caspase-3.
Ellagic acid metabolizes to urolithins-A in the gut,
which exerts a remarkable antiproliferative activity in
human colon cancer cells (Caco-2, SW-480 and HT-29)
(Gonza´lez-Sarrı´as et al. 2005). The treatment of ellagic
acid with PC3 cells results in a dose-dependent inhibition
of cell growth/cell viability accompanied by induction of
apoptosis and cleavage of poly(ADP-ribose) polymerase
(PARP) and morphological changes. Ellagic acid induces
apoptosis by upregulation of c-fos and pS2 protein in MCF-
7; whereas, it follows intrinsic pathway in MDA-MB-231
cells. Hence, ellagic acid may have different pathways or
antiproliferative activity on human breast cancer cell lines
(Kim et al. 2009).
It has also been shown previously that NPs interfere
with the MTT assay by adsorbing the tetrazolium salt
(Wo¨rle-Knirsch et al. 2006), or by releasing metal ions
which modify the catalytic activity of the mitochondrial
reductases (Kroll et al. 2009). Gurunathan et al. (2013a, b)
revealed that the potential cytotoxic effect of biologically
synthesized AgNPs in MDA-MB-231 cells accompanied
by inhibiting the growth of cells, concentration-dependent
activation of LDH, increased level of ROS generation and
activation of caspase-3 are considered to be the most sig-
nificant of the executioner caspases resulting in cellular
apoptosis.
The mode of action of AgNPs and ellagic acid portrays
AgNPs embedded with ellagic acid to inhibit the prolifer-
ation of MCF-7 cells through Bax/BCl2 and caspase cas-
cade-mediated mitochondrial dysfunction accompanied by
the TGF-b/Smad3 pathway. The combination of these
pathways may be the reason for the increased rate of cell
inhibition even at lower concentration. Thus, the AgNPs
fabricated ellagic acid exhibits 99 % anti-proliferation at a
concentration of 25 lL/mL. The present result was found
to be valid on comparing with that of the cell inhibition
acquired using individual components viz, ellagic acid and
AgNPs.
Conclusion
Plant-mediated synthesis of silver nanoparticles using the
extract of A. sessilis by sonication method advocates green
nanotechnology. The results of the present cytotoxic study
against human breast cancer MCF-7 cell lines by MTT
assay revealed that silver nanoparticles serve as a potential
anticancer drug compared to the standard cisplatin.
Nanosilver showed excellent apoptosis rate due to their
smaller size and spherical morphology. The present study
contributes a novel and alternate approach in cancer ther-
apy. The novelty of the present research is that complete
cell inhibition (99 %) of breast cancer cell lines with plant-
mediated nanosilver particles is obtained with 25 lg/mL,
whereas it is 30 lg/mL for cisplatin, the standard drug used
in breast cancer. Use of this edible plant extract eliminates
the need to remove toxic byproducts during the formation
of silver nanoparticles. Further studies are needed to opti-
mize the mechanism of AgNPs on cancer cells.
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